Enjoy complimentary customisation on priority with our Enterprise License!
The pharmaceutical glass packaging market size is forecast to increase by USD 7.73 billion at a CAGR of 7.44% between 2023 and 2028. The market is experiencing significant expansion, driven by key factors. Notably, substantial R&D investments in the sector fuel market growth. This trend is particularly evident in the pharmaceutical industry, where innovation and technological advancements are paramount. Additionally, the increasing sales of pharmaceuticals, underpinned by a growing global population and rising healthcare expenditures, contribute to market expansion. Furthermore, the adoption of cryogenic vials in drug research and development is a significant market trend. These vials, which maintain the low temperatures required for certain pharmaceutical compounds, enhance the efficacy and safety of drugs. As a result, the market is poised for robust growth, with these factors playing a crucial role in its expansion.
It also includes an in-depth analysis of market trends and analysis, market growth analysis and challenges. Furthermore, the report includes historic market data from 2018 - 2022.
To learn more about this report, View Report Sample
The market relies on materials like limestone, soda ash, and sand for its chemical composition, ensuring the integrity of generic injectable drugs. With Medicare emphasizing cost-sensitivity, pharmaceutical companies opt for glassware due to its reliability and safety. This market segment caters to healthcare facilities with solutions such as single-dose vials and prefilled syringes, minimizing contamination risks. Additionally, the use of atmospheric gases like carbon dioxide and oxygen preserves drug potency in primary pharmaceutical glass container, meeting stringent quality standards. The market relies on materials such as Limestone (CaCO3), Soda ash (Na2CO3), Cullet and sand to create its primary containers, ensuring the safety and integrity of biotech drugs. These containers, composed of barium, zinc, Magnesium, Aluminum, Boron and ferrous elements, play a crucial role in preserving the efficacy of pharmaceutical products. With rising national health spending, the demand for high-quality packaging continues to grow, driven by the need for reliable and sustainable solutions to store and deliver medications effectively and national health spending. Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increase in R&D spending in the pharmaceutical industry is notably driving market growth. Many pharmaceutical companies are making significant R&D investments. A company typically invests between 15% and 20% of its revenue in research and development. The number of pharmaceutical products on the market is anticipated to rise, driving demand as a result of increased R&D spending by manufacturers.
Pharmaceutical manufacturers can lower their capital expenditure and associated operating costs with regard to the purchase of glass packaging machinery, space for setting up a glass packaging unit, and labor costs by outsourcing glass packaging operations to third-party companies. Pharmaceutical manufacturers also focus on their core competencies by contracting with outside providers of packaging services. Therefore, the rising R&D spending by pharmaceutical manufacturers and increasing production of pharmaceutical products such as biologics, vials, and others are expected to increase the demand during the forecast period.
The expansion of manufacturing facilities is an emerging trend in the market. The companies are expanding their manufacturing facilities to keep up with the demand for pharmaceutical products like medicines, vaccines, and other goods.
One of the instances of expansion by the companies includes the announcement made by Schott AG in November 2021 in its new pharma glass tubing factory in Jinyun, China, to meet the growing demand for high-quality glass tubing for primary pharmaceutical packaging. Similarly, Piramida, a Croatian manufacturer of glass pharmaceutical packaging, was purchased by Nipro Corp. in May 2021. The acquisition will enable Piramida to strengthen its position in Europe and other international markets while enabling Nipro to meet the rising demand in the Central European market. Thus, the growing expansion of manufacturing facilities by the companies will drive the market during the forecast period.
The risk of counterfeiting in pharmaceutical glass packaging is a major challenge impeding market growth. The lives of consumers may be in danger from counterfeit drugs. companies of glass and pharmaceutical packaging may also suffer financially as a result. Additionally, the consequences of using fake medications can harm a company's reputation. There are numerous intermediaries in the complex global pharmaceutical supply chain. Consequently, there is a chance that the genuine item will be taken or changed for a replica. Before the drugs reach the final consumer, the original drugs may be replaced or stolen at either the beginning or the end of the supply chain.
The companies are increasingly investing and adopting anti-counterfeit techniques in packaging, such as security printing (comprises micro text, watermark, and latent image), track and trace (such as barcodes and serialization), covert identifiers and trace (includes micro taggants and micro-mapping), and holography (holograms, embedded barcodes, logos, and hidden messages). However, this will increase the cost of production, which in turn will decrease the vendor's profit margins. Therefore, such factors will hinder the market growth during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Arab Pharmaceutical Glass Co. - The company's key offerings include pharmaceutical glass packaging solutions such as vials, jars, and bottles.
The research report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth by the generic segment will be significant during the forecast period. Glass has many advantages as a packaging material, including sustainability, inertness, impermeability, recyclability without losing quality, and reusability. It is the perfect material for securely storing and shielding products. Glass packaging is therefore used for a variety of generic drugs due to its advantages.
Get a glance at the market contribution of various segments View the PDF Sample
The generic segment was valued at USD 9.59 billion in 2018. Since generic drug applicants do not need to repeat the animal and clinical (human studies) studies that were necessary to prove the safety and efficacy of name-brand medications, generic medications are more affordable than branded ones. Due to lower initial drug development costs, generic drug companies are able to offer their products at prices that are about 85% lower than those of their brand-name counterparts. Generic medications also contain identical active ingredients that are comparable to the branded medication's strength, stability, purity, efficacy, and safety. The acceptance of generic medications due to their low cost has also made it possible for developing nations to access these medications for the treatment of various diseases. Therefore, the low cost of generics, their growing use in emerging markets, and their effectiveness lead people to opt for generic drugs, thereby contributing to the growth of the market during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The region's demand is anticipated to increase significantly due to the growing elderly population in North America. By 2035, there will be more than 78 million elderly people (those over 65), according to the US Census Bureau. The demand for value-added goods is fueled by regulatory standards that promote senior-friendly pharmaceutical packaging options with extra security features like child-resistant closures. During the forecast period, it is also anticipated that increasing tin and steel plating for the production of caps and a shift in consumer preference toward plastic substitutes like glass in beverage packaging will aid in the market's expansion.
The US is the major contributor to the market in North America. The growing value of the US pharmaceutical exports, increasing healthcare spending, and the rising aging population are the major factors driving the market. The expansion of government healthcare insurance programs also fuels the market. The US system of intellectual property is driving up the market price of patented medicines. As a result, the US pharmaceutical industry is drawing a lot of venture capital investment. The rising healthcare spending in the US is also anticipated to increase demand in the nation over the course of the forecast period.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The market is vital for ensuring the integrity and safety of medications. With materials like sand (SiO2) and calcium, pharmaceutical glass manufacturers adhere to strict regulations set by agencies such as the Centers for Medicare & Medicaid Services and the Department of Defense healthcare programs. From Type I borosilicate vials to Corning Velocity Vials, these containers protect drugs from degradation due to hydrolysis and oxidation, extending their shelf life. As product demand increases, the market focuses on developing environmentally friendly packaging solutions and adopting sustainable practices. Incorporating intelligent packaging technologies like RFID tags and tamper-evident features addresses concerns over drug stability and compliance with tightening regulations.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
176 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.44% |
|
Market Growth 2024-2028 |
USD 7.73 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
6.4 |
|
Regional analysis |
North America, APAC, Europe, South America, and Middle East and Africa |
|
Performing market contribution |
North America at 36% |
|
Key countries |
US, Russia, China, UK, and India |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Acme Vial and Glass Co. LLC, Arab Pharmaceutical Glass Co., Ardagh Group SA, Beatson Clark, Becton Dickinson and Co., Bormioli Pharma Spa, Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Hindustan National Glass and Industries Ltd., Nipro Corp., O I Glass Inc., PGP Glass Pvt. Ltd., SCHOTT AG, SGD Pharma, Shandong Pharmaceutical Glass Co. Ltd., Stevanato Group S.p.A, Stoelzle Oberglas GmbH, TURKIYE SISE VE CAM FABRIKALARI A.S., and West Pharmaceutical Services Inc. |
|
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.